ID.1
Item
histologically confirmed non small cell lung cancer (nsclc) or small cell lung cancer (sclc) clinically diagnosed providing that fdg-pet is positive.
boolean
C0007131 (UMLS CUI [1,1])
C0149925 (UMLS CUI [1,2])
C3899175 (UMLS CUI [1,3])
ID.2
Item
stage i to iii lung cancer requiring definitive irradiation with or without chemotherapy.
boolean
C0242379 (UMLS CUI [1,1])
C1522449 (UMLS CUI [1,2])
vID.3
Item
patients with a locoregional tumor recurrence following surgery will be eligible provided they meet other eligibility criteria.
boolean
C1947913 (UMLS CUI [1])
ID.4
Item
patients must be 18 years of age or older.
boolean
C0001779 (UMLS CUI [1])
ID.5
Item
female patients with reproductive capability must be willing to use effective contraception
boolean
C0009862 (UMLS CUI [1])
ID.6
Item
patients must sign an informed consent form for study.
boolean
C0021430 (UMLS CUI [1])
ID.7
Item
malignant pleural or pericardial effusion.
boolean
C0080032 (UMLS CUI [1,1])
C0220655 (UMLS CUI [1,2])
ID.8
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
ID.9
Item
lactation
boolean
C0006147 (UMLS CUI [1])
ID.10
Item
patients with diabetes mellitus, with uncontrolled fasting blood glucose level (above 200 mg/dl)
boolean
C0421258 (UMLS CUI [1])
ID.11
Item
inability to lie flat for the duration of pet/ct and v/q spect (approximately 45 minutes for each study)
boolean
C0555089 (UMLS CUI [1])
ID.12
Item
prisoners are excluded from this study.
boolean
C0033167 (UMLS CUI [1])